Assignee
NASHPHARM
FR·1 granted patent·1 pending application·3 citations·filing 2017–2017
Top patents by PatentIndex Score
2 records- 0175US11185520B2Composition comprising at least one water-soluble pharmaceutically acceptable salt of elafibranor having improved intestinal absorptionNASHPHARM·Filed 2017·Granted Nov 30, 2021·3 cites·17 claims
- 0233US2020023067A1Dual-action elafibranor metformin salt for treating obesity associated with non-alcoholic steatohepatitis (nash) and hypertriglyceridaemiaNASHPHARM·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →